Zyden Gentec Ltd - Stock Valuation and Financial Performance

BSE: 530091 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Zyden Gentec

M-Cap below 100cr DeciZen not available

Zyden Gentec stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
4.8 Cr.
52-wk low:
0.9
52-wk high:
1

Is Zyden Gentec Ltd an attractive stock to invest in?

1. Is Zyden Gentec Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Zyden Gentec Ltd is a below average quality company.

2. Is Zyden Gentec Ltd undervalued or overvalued?

No data found

3. Is Zyden Gentec Ltd a good buy now?

No data found

10 Year X-Ray of Zyden Gentec:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Zyden Gentec Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % 3.7%3.3%-14.9%-1.9%-1%-0.1%1.7%-0.1%-2.4%-12.9%-
Value Creation
Index
-0.7-0.8-2.1-1.1-1.1-1.0-0.9-1.0-1.2-1.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 17.512.19.57.61.60.30.40.10.71.21
Sales YoY Gr.--30.9%-21.4%-20.6%-78.9%-78.6%5.9%-86.1%1,380%55.4%-
Adj EPS 0-0-0.7-0.1-0.1-00.10-0.3-0.3-0.7
YoY Gr.--200%NANANANANA-100%NANA-
BVPS (₹) 3.43.32.32.32.22.22.22.21.81.12.4
Adj Net
Profit
0.1-0.1-4.1-0.7-0.300.30-1.5-1.4-4
Cash Flow from Ops. 4-1.6-1.83.70.30-2.4-0.5-5.30.1-
Debt/CF from Ops. 1-6.2-6.33.237.9-4897.5-3.3-14.7-0.923.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -26.1%-6.3%47.3%55.4%
Adj EPS -223.1%NA-263%NA
BVPS-11.9%-13.5%-20.5%-38.6%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
1.3-1.2-36.9-5.7-2-0.32.8-0.1-14.2-18.2-39.3
Op. Profit
Mgn %
4.29.7-30.5-13.4-81.1-115.589.2-24.248-37.7NAN
Net Profit
Mgn %
0.6-0.9-43-9.7-15.9-12.296.3-24.6-207.5-125.1-328.5
Debt to
Equity
0.51.20.90.90.80.80.70.60.50.3-
Working Cap
Days
1833385437713,36615,09915,8511,05,0657,4023,6410
Cash Conv.
Cycle
1011522011879743,505-6,60,63624,4271,8618890

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 47.28%

Return on Equity is Poor

Net Profit has been subdued in last 3 years -263.03%

Sales growth is not so good in last 4 quarters at -50.00%

Latest Financials - Zyden Gentec Ltd.

Standalone Consolidated
TTM EPS (₹) -0.7 0.1
TTM Sales (₹ Cr.) 1.2 0
BVPS (₹.) 2.4 2.3
Reserves (₹ Cr.) 2 1
P/BV 0.37 0.39
PE 0.00 8.56
From the Market
52 Week Low / High (₹) 0.87 / 0.95
All Time Low / High (₹) 0.16 / 35.80
Market Cap (₹ Cr.) 4.8
Equity (₹ Cr.) 11.1
Face Value (₹) 2
Industry PE 47.5

Management X-Ray of Zyden Gentec:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *58.420.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Zyden Gentec

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales17.5212.109.517.551.590.340.360.050.741.15
Operating Expenses 16.7810.9212.438.562.900.731.590.073.131.58
Manufacturing Costs0.781.451.110.860.2600000
Material Costs14.418.169.926.612.060.3200.050.351.53
Employee Cost 0.740.870.990.760.360.04000.010.01
Other Costs 0.850.440.420.320.230.371.580.022.770.03
Operating Profit 0.741.18-2.92-1.01-1.31-0.39-1.23-0.01-2.39-0.43
Operating Profit Margin (%) 4.2%9.7%-30.7%-13.4%-82.2%-115.0%-345.0%-24.2%-322.0%-37.7%
Other Income 0.090.020.110.941.330.380.8601.880
Interest 0.470.901.240.400.030.03001.620
Depreciation 0.170.320.410.260.2500000
Exceptional Items 00000000-0.05-3.34
Profit Before Tax 0.20-0.02-4.46-0.73-0.26-0.04-0.37-0.01-2.18-3.77
Tax 0.080.08-0.360000000
Profit After Tax 0.12-0.11-4.10-0.73-0.26-0.04-0.37-0.01-2.18-3.77
PAT Margin (%) 0.7%-0.9%-43.1%-9.7%-16.6%-12.2%-103.0%-24.6%-294.0%-329.0%
Adjusted EPS (₹)0.10.0-0.7-0.1-0.10.0-0.10.0-0.4-0.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 8.588.4712.9712.6312.3612.3211.9511.949.765.98
Share Capital 5.075.0711.1111.1111.1111.1111.1111.1111.1111.11
Reserves 3.523.411.851.521.251.210.840.83-1.36-5.13
Minority Interest0000000000
Debt3.939.5710.707.075.415.174.114.514.542.01
Long Term Debt3.932.954.330000000
Short Term Debt06.616.387.075.415.174.114.514.542.01
Trade Payables2.771.751.0711.551.210.970.970.080.06
Others Liabilities 0.442.631.655.605.154.983.943.340.470.07
Total Liabilities 15.7322.4226.3926.3024.4723.6920.9820.7514.858.12

Fixed Assets

Gross Block4.259.8310.0210.059.999.997.077.060.070.07
Accumulated Depreciation0.540.861.271.521.741.741.741.740.020.02
Net Fixed Assets3.708.978.758.538.258.255.335.330.050.05
CWIP 0.620.080.080000000
Investments 0000.010.0100000
Inventories2.925.992.531.270.690.690.690.690.690
Trade Receivables3.943.092.154.694.694.113.844.044.310.73
Cash Equivalents 0.200.250.110.120.030.150.030.100.030
Others Assets4.344.0512.7911.6810.8010.4811.0910.609.777.35
Total Assets 15.7322.4226.3926.3024.4723.6920.9820.7514.858.12

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity 3.98-1.61-1.783.690.260-2.36-0.50-5.330.09
PBT 0.20-0.02-4.46-0.73-0.26-0.04-0.37-0.01-2.18-3.77
Adjustment 1.071.121.54-0.27-1.03-0.350.6900.870
Changes in Working Capital 2.74-2.671.154.691.550.39-2.12-0.49-4.013.86
Tax Paid -0.02-0.0300000000
Cash Flow From Investing Activity -4.68-4.25-6.440.351.340.392.240.505.452.41
Capex -0.80-5.03-0.20-0.040.0201.91000
Net Investments 0000000000
Others -3.880.79-6.240.391.330.390.330.505.452.42
Cash Flow From Financing Activity 0.855.918.08-4.03-1.69-0.2700.07-0.19-2.53
Net Proceeds from Shares 0.340.608.100000000
Net Proceeds from Borrowing 02.781.37-4.330000.0700
Interest Paid -0.42-0.82-1.16-0.39-0.0300000
Dividend Paid 0000000000
Others 0.943.35-0.240.69-1.65-0.2700-0.18-2.53
Net Cash Flow 0.160.05-0.140.01-0.090.11-0.120.07-0.07-0.03
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)1.54-1.27-38.24-5.71-2.12-0.34-3.04-0.11-20.13-47.91
ROCE (%)5.695.54-14.83-1.36-0.99-0.04-1.75-0.07-3.36-33.84
Asset Turnover Ratio1.370.690.420.320.070.020.0200.040.1
PAT to CFO Conversion(x)33.17N/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days7598931509344,2234,07702,054803
Inventory Days63124151831956647104,7003410
Payable Days4110152572261,59307,01054317

Zyden Gentec Ltd Stock News

Zyden Gentec Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Zyden Gentec on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Zyden Gentec stood at ₹4.83.
The latest P/E ratio of Zyden Gentec as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Zyden Gentec as of 01-Jan-1970 05:30 is 0.37.
The 52-week high of Zyden Gentec is ₹0.95 and the 52-week low is ₹0.87.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zyden Gentec is ₹1.15 ( Cr.) .

About Zyden Gentec Ltd

Zyden Gentec was incorporated on April 26, 1994 under the companies Act 1956 as Overseas Capital Private Limited. The name of the company was changed to Overseas Capital Limited on conversion into public limited company on November 11, 1994 and to Zyden Gentec Limited on July 16, 2004. The company was promoted by RK Dhar.

Initially the company was engaged in providing financial services and is presently engaged in the manufacturing of pharmaceuticals and fine chemicals.

Product range of the company includes:

The company's principal activity is to manufacture pharmaceutical products and to provide concultancy services. The company operates in two segments namely Manufacturing & Allied Activities and Financial, Investment & Allied Activities. The products of the company include specialized chemicals, bulk drugs, compounds and intermediates

  • Drotaverine HCL
  • Levocetrizine
  • Ketoconazole
  • Sildenafil Citrate
  • Glucosamine
  • Ciprofloxacin HCL
  • Enro Floxacin
  • Bypyridine
  • Guaifenesin
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.